Dr. Adrian Miranda, MD | Source | Senior VP of Science and Technology and Chief Medical Officer at NeurAxis
Dr. Adrian Miranda, MD
Dr. Miranda brings a unique background of research and clinical expertise to his role as Chief Medical Officer of NeurAxis. He is a Professor of Pediatrics and a board-certified Pediatric Gastroenterologist. He obtained his undergraduate degree in Biology from San Diego State University and obtained his medical degree from the Medical College of Wisconsin. He completed his residency and subspecialty training in Pediatric Gastroenterology at Children’s Hospital of Wisconsin (CHW).
-
NeurAxis
Senior VP of Science and Technology and Chief Medical Officer
-
NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device
CARMEL, Ind., Nov. 08, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced it has executed an exclusive option agreement with the University of Michigan for the exclusive licensing of its innovative rectal expulsion device (RED). The RED redesigns the balloon expulsion testing workflow to directly s
Article
-
Chronic constipation aligns well with NeurAxis’ focus and expertise in the field of disorders of the gut-brain interaction. The economic impact of adult chronic constipation in the U.S. is significant, with an estimated 2.5 million physician visits annually. Like IBS, chronic constipation also negatively impacts health-related quality of life, including psychological and social consequences. RED is a highly sensitive screening tool for evacuation disorders that will effectively and efficiently identify the underlying cause of symptoms allowing clinicians to tailor treatment and minimize unnecessary testing with a point-of-care test.
